The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of body mass index change and insulin resistance with survival during induction therapy in newly diagnosed multiple myeloma.
 
Ram Prakash Thirugnanasambandam
No Relationships to Disclose
 
Ross Firestone
No Relationships to Disclose
 
Andriy Derkach
No Relationships to Disclose
 
Tala Shekarkhand
No Relationships to Disclose
 
Colin Rueda
No Relationships to Disclose
 
Kylee Maclachlan
No Relationships to Disclose
 
Malin Hultcrantz
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Curio Science; GlaxoSmithKline; Intellisphere; Janssen Oncology; Projects in Knowledge
Research Funding - Abbvie; Amgen (Inst); BeiGene; Bristol-Myers Squibb/Celgene; Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Janssen; SpringWorks Therapeutics
 
Sham Mailankody
Honoraria - OncLive/MJH Life Sciences; Physicans' Education Resource; Plexus
Consulting or Advisory Role - Abbvie; Arcellx; Bristol Myers Squibb Foundation; Bristol Myers Squibb Foundation; Galapagos UK; Janssen Oncology; Legend Biotech; Optum; Optum
Research Funding - Alimera Sciences (Inst); Bristol-Myers Squibb (Inst); Caribou Biosciences; Fate Therapeutics; Fate Therapeutics; Janssen Oncology (Inst); Juno Therapeutics (Inst); Takeda (Inst)
 
Dhwani Patel
No Relationships to Disclose
 
Heather Landau
Consulting or Advisory Role - Abbvie/Genentech; Nexcella; Prothena
Research Funding - Alexion Pharmaceuticals (Inst); Janssen Oncology (Inst); Nexcella (Inst); Protego Biopharma (Inst); Prothena (Inst)
 
Gunjan Shah
Consulting or Advisory Role - Arcellx
Research Funding - Amgen (Inst); BeyondSpring Pharmaceuticals (Inst); Bristol-Myers Squibb/Celgene (Inst); GPCR Therapeutics (Inst); Janssen (Inst); Recordati (Inst)
 
Michael Scordo
Honoraria - Cancer Network; i3 CME; Medscape
Consulting or Advisory Role - Angiocrine Bioscience; Kite/Gilead; McKinsey & Company; Miltenyi Biotec; Omeros
Research Funding - Amgen (Inst); Angiocrine Bioscience (Inst); Bristol-Myers Squibb/Celgene (Inst); Omeros (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Kite/Gilead
 
Hani Hassoun
Research Funding - Janssen; Takeda
 
Alexander Lesokhin
Honoraria - ITeos Therapeutics; Janssen; Legend Biotech; Pfizer; Sanofi; SVB Leerink; SVB Leerink; Trillium Therapeutics
Consulting or Advisory Role - Arcellx; Pfizer; Trillium Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix, Inc
 
Sergio Giralt
Honoraria - Amgen; Jazz Pharmaceuticals; Sanofi
Consulting or Advisory Role - Actinuum; Amgen; Bristol-Myers Squibb; Incyte; Janssen; Jazz Pharmaceuticals; Johnson & Johnson; Pfizer; Sanofi
Research Funding - Actinuum; Amgen; Celgene (Inst); Johnson & Johnson; Miltenyi Biotec (Inst); Sanofi
Travel, Accommodations, Expenses - Amgen; Celgene; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Sanofi
 
Michael Pollak
No Relationships to Disclose
 
Neha Korde
Honoraria - Cancer Network; Clinical Care Options; Intellisphere; Onc Live; PER; Remedy Health
Consulting or Advisory Role - Janssen Oncology
Research Funding - Abbvie; Amgen; Epizyme; Janssen
Travel, Accommodations, Expenses - Dava oncology
 
Saad Usmani
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb/Celgene; Genentech; GlaxoSmithKline; Janssen Oncology; Oricell Therapeutics; Regeneron
Research Funding - Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Gracell Therapeutics; Janssen Oncology; K36 Therapeutics
 
Carlyn Tan
No Relationships to Disclose
 
Urvi Shah
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Janssen Oncology; Sanofi
Research Funding - Celgene/Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); M and M labs (Inst); Sabinsa Corporation (Inst)